Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.

Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K.

Clin Pharmacol Ther. 2002 Jul;72(1):50-61.

PMID:
12152004
2.

COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.

Whelton A.

J Hypertens Suppl. 2002 Sep;20(6):S31-5. Review.

PMID:
12683425
3.

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.

PMID:
14564311
4.

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.

Phelan KM, Mosholder AD, Lu S.

J Clin Psychiatry. 2003 Nov;64(11):1328-34. Review.

PMID:
14658947
5.

Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).

Graham GG, Graham RI, Day RO.

Curr Pharm Des. 2002;8(12):1063-75. Review.

PMID:
11945151
6.

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.

Whelton A, Maurath CJ, Verburg KM, Geis GS.

Am J Ther. 2000 May;7(3):159-75. Review. Erratum in: Am J Ther 2000 Sep;7(5):341.

PMID:
11317165
7.

Cyclooxygenase-2 inhibition and renal physiology.

Harris RC Jr.

Am J Cardiol. 2002 Mar 21;89(6A):10D-17D. Review.

PMID:
11909556
8.

Renal failure associated with the use of celecoxib and rofecoxib.

Ahmad SR, Kortepeter C, Brinker A, Chen M, Beitz J.

Drug Saf. 2002;25(7):537-44. Review.

PMID:
12093311
9.

Celecoxib, rofecoxib, and acute temporary visual impairment.

Coulter DM, Clark DW, Savage RL.

BMJ. 2003 Nov 22;327(7425):1214-5. Review. No abstract available.

10.

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.

Brater DC.

Am J Med. 1999 Dec 13;107(6A):65S-70S; discussion 70S-71S. Review.

PMID:
10628595
11.

Nephrotoxicity of selective COX-2 inhibitors.

Woywodt A, Schwarz A, Mengel M, Haller H, Zeidler H, Köhler L.

J Rheumatol. 2001 Sep;28(9):2133-5. Review.

PMID:
11550988
12.

Cardiovascular and renal effects of COX-2-specific inhibitors: recent insights and evolving clinical implications.

Epstein M.

Am J Ther. 2001 Mar-Apr;8(2):81-3. Review. No abstract available.

PMID:
11304661
14.

Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Hörl WH.

Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321. Review.

Supplemental Content

Support Center